Across the recent three months, 4 analysts have shared their insights on Gritstone Bio (NASDAQ:GRTS), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 1 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $3.38, a high estimate of $5.00, and a low estimate of $0.50. Observing a downward trend, the current average is 20.47% lower than the prior average price target of $4.25.
Decoding Analyst Ratings: A Detailed Look
The analysis of...
Login or create a forever free account to read this news
Sign up/Log in
